MedPlus To Sell Over 500 Off-Patent Drugs At Huge Discounts

Hyderabad : MedPlus Health Services, which runs a chain of pharmacies, said it will be selling 500 off-patent therapeutic and chronic medicines under its own brand with a discount of 50-80 per cent.

Announcing this at a press conference on Wednesday, G Madhukar Reddy, managing director and chief executive officer, MedPlus, said the company tied up with multiple reputed pharmaceutical manufacturing companies to produce high quality off-patent medicines that enables the firm to pass on the benefit to the consumer.

“MedPlus will initially offer discounts on over 500 therapeutic and chronic medicines and will eventually extend discounts on more than 800 products in the next three months,” Reddy said.

These medicines will include over-the-counter (OTC) and prescription drugs used in treating various diseases such as hypertension, diabetes and kidney ailments, he said.

The 500 products currently being offered cover about 53 per cent of the therapeutic segments and the products will be sold under the MedPlus brand, he added.

Currently, it operates about 3,800 stores and has plans to add another 800 new pharmacies during 2023-24.  “Our size allows us to eliminate marketing, distribution and other retail costs and will pass on the benefits to customers,” he said.

  • Related Posts

    • Pharma
    • June 25, 2025
    • 104 views
    Novo Nordisk launches blockbuster weight-loss drug Wegovy in India; Check price, dosage and other details

    A major face-off is expected in India’s growing anti-obesity treatment market, as Danish pharma giant Novo Nordisk rolled out its blockbuster weight-loss drug Wegovy on Tuesday, just a month after…

    • Pharma
    • June 25, 2025
    • 111 views
    Aurobindo Pharma arm gets marketing authorization in UK for Dyrupeg

    Hyderabad:  Aurobindo Pharma Ltd wholly owned step-down subsidiary CuraTeQ Biologics has obtained marketing authorization from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) for Dyrupeg, its pegylated filgrastim biosimilar…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Novo Nordisk launches blockbuster weight-loss drug Wegovy in India; Check price, dosage and other details

    Novo Nordisk launches blockbuster weight-loss drug Wegovy in India; Check price, dosage and other details

    Aurobindo Pharma arm gets marketing authorization in UK for Dyrupeg

    Aurobindo Pharma arm gets marketing authorization in UK for Dyrupeg

    Sun Pharma’s European partner withdraws application for skin cancer treatment therapy

    Sun Pharma’s European partner withdraws application for skin cancer treatment therapy

    Glenmark Pharma launches TEVIMBRA in India

    Glenmark Pharma launches TEVIMBRA in India